HomeThemesTypesDBAbout
Showing: ◈ EMA×
Six years after the referendum we can disentangle the evidence and judge the effects on health and care, says Richard Vize.
Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers.
BREXIT is causing “damage across the board” to UK science, including missing out on more than £1 billion in funding, campaigners have warned.
A new EU directive is allowing member states to remove the charge for ‘supply and installation of solar panels’.
There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.
Britain must work with other countries to prevent friction on medicine rules post-Brexit to avoid being sidelined by the global drug industry, according to a report from the U.K.’s biggest pharmaceutical lobby group.
The government and its supporters are beginning to claim 'benefits' of being outside the European Union some of which were always available to EU member states or, in other cases, are not benefits at all.
Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions.
This note summarises the evidence so far of the impacts on Brexit on Scotland. It sets out early evidence related to areas such as trade, the workforce and EU programmes.
Dr Philippa Whitford, MP and eminent breast cancer surgeon, shares her concerns for the future of our NHS following Brexit. Recorded in front of a live audience at Arran High School Theatre on Friday 13th September 2019.
NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU? Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage.
Relocation to Amsterdam will give better access to European markets ‘regardless of Brexit outcome’.
[BrexitDB NOTE: These agencies have now left the UK.] Wrangle around European Medicines Agency and European Banking Authority after Brussels insists they must leave UK.
Education secretary lauds vaccine rollout saying scientists in UK better than in France, Belgium or US.
Preparing Brexit: How ready is the UK? is our second report examining government and business preparations for the end of the transition period, building on Preparing Brexit: The scale of the task left for UK government and business, published in July.
And it will cost more here because of the UK pulling out of the European Medicines Agency on 30 December.
The most important Brexit event of the week came and went with relatively little fanfare, yet it marks a significant moment.
The negotiations which will set our relationship with our closest neighbours for the next generation are being rushed in a reckless game of chicken.
Everyone is fishing in the same pond. Stocks built up in readiness for Brexit are having to be replenished. If another pandemic strikes, we’ll hardly be in the best position to get through it.
A coronavirus vaccine could be ready for approval in a year’s time in an “optimistic scenario”, the European Medicines Agency has said.
More than three quarters of the public think the UK should participate in EU schemes to secure vital protective equipment, as it emerged ministers passed on three opportunities to take part.
Experts warn that European Medicines Agency membership would have had advantages.